CompletedNot Applicable

Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis

United States60 participantsStarted 2020-07-10

Plain-language summary

The objective of this study is to administer and validate a disease specific health related quality of life (HRQOL) survey for patients with Chronic Hypersensitivity Pneumonitis (CHP).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 18 years old or older
✓. Understand and sign the informed consent document
✓. Documented diagnosis of HP made and confirmed at an ILD center via expert consensus or in multidisciplinary discussion
✓. HP must be the primary pulmonary disease
✓. Anticipated ability to complete follow up survey within 2 weeks of initial survey completion
✓. Participants recruited from the PFF registry must have agreed to be contacted for ancillary research studies.

Exclusion criteria

✕. Non-English Speaking (Patient must be able to speak and read English fluently but it does not have to be their primary language)
✕. Inability to complete questionnaire due to cognitive impairment
✕. Patients who have not been seen by or communicated with their provider in over 2 years

What they're measuring

Validation of a health-related quality of life instrument for patients with Chronic Hypersensitivity Pneumonitis

Timeframe: Day 0

Validation of a health-related quality of life instrument for patients with Chronic Hypersensitivity Pneumonitis by administering the Short Form (SF-12) Survey

Timeframe: Day 0

Validation of a health-related quality of life instrument for patients with Chronic Hypersensitivity Pneumonitis by administering the King's Brief Interstitial Lung Disease Questionnaire

Timeframe: Day 0

Change in Health-related Quality of Life Assessment Score

Timeframe: 2 weeks following Day 0

Trial details

NCT IDNCT04273867

SponsorWeill Medical College of Cornell University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-02-22

View on ClinicalTrials.gov More Hypersensitivity Pneumonitis trials

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 18 years old or older
✓. Understand and sign the informed consent document
✓. Documented diagnosis of HP made and confirmed at an ILD center via expert consensus or in multidisciplinary discussion
✓. HP must be the primary pulmonary disease
✓. Anticipated ability to complete follow up survey within 2 weeks of initial survey completion
✓. Participants recruited from the PFF registry must have agreed to be contacted for ancillary research studies.

Exclusion criteria

✕. Non-English Speaking (Patient must be able to speak and read English fluently but it does not have to be their primary language)
✕. Inability to complete questionnaire due to cognitive impairment
✕. Patients who have not been seen by or communicated with their provider in over 2 years

What they're measuring

Validation of a health-related quality of life instrument for patients with Chronic Hypersensitivity Pneumonitis

Timeframe: Day 0

Validation of a health-related quality of life instrument for patients with Chronic Hypersensitivity Pneumonitis by administering the Short Form (SF-12) Survey

Timeframe: Day 0

Validation of a health-related quality of life instrument for patients with Chronic Hypersensitivity Pneumonitis by administering the King's Brief Interstitial Lung Disease Questionnaire

Timeframe: Day 0

Change in Health-related Quality of Life Assessment Score

Timeframe: 2 weeks following Day 0